Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 19NIH 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Lymphoid Interstitial Pneumonia 1Breast Neoplasms 1

Interventions

Cyclophosphamide 388Specimen Handling 377Magnetic Resonance Spectroscopy 328Radiotherapy 306Biopsy 273Cisplatin 258Carboplatin 255Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 183Bevacizumab 181Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 141Taxes 127Docetaxel 122Chemotherapy, Adjuvant 114Oxaliplatin 113fludarabine phosphate 111Methotrexate 108Rituximab 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NIH × Soybean Proteins × Clear all
NCT02007200 2016-10-24

Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery

National Cancer Institute (NCI)

Phase 2 Completed
55 enrolled 8 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

NCT00003100 2013-12-19

Dietary Soy Isoflavones for the Prevention of Cancer

National Cancer Institute (NCI)

Phase NA Unknown
90 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00513916 2013-12-19

Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women

National Cancer Institute (NCI)

Phase 3 Completed
100 enrolled
Breast

Breast Neoplasms

NCT00765479 2013-09-20

Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer

National Cancer Institute (NCI)

Phase 2/3 Completed
284 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡